Meridian Management’s Bristol-Myers Squibb BMY Stock Holding History

Meridian Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$851K	Hold	14,037	–	–	0.21%	56
2025 Q4	$757K	Sell	14,037 -8	-0.1%	-$385	0.19%	53
2025 Q3	$633K	Hold	14,045	–	–	0.17%	56
2025 Q2	$608K	Sell	14,045 -220	-2%	-$10.8K	0.17%	54
2025 Q1	$870K	Sell	14,265 -14,208	-50%	-$828K	0.27%	45
2024 Q4	$1.61M	Buy	28,473 +190	+0.7%	+$10.6K	0.42%	42
2024 Q3	$1.46M	Buy	28,283 +182	+0.6%	+$8.54K	0.37%	43
2024 Q2	$1.17M	Buy	28,101 +32	+0.1%	+$1.43K	0.32%	48
2024 Q1	$1.52M	Sell	28,069 -55	-0.2%	-$2.8K	0.42%	43
2023 Q4	$1.4M	Buy	28,124 +253	+0.9%	+$13.3K	0.4%	43
2023 Q3	$1.62M	Sell	27,871 -20,810	-43%	-$1.28M	0.53%	40
2023 Q2	$3.11M	Sell	48,681 -23	-0%	-$1.54K	0.98%	27
2023 Q1	$3.38M	Buy	48,704 +12,153	+33%	+$857K	1.11%	26
2022 Q4	$2.63M	Buy	36,551 +22,086	+153%	+$1.67M	0.96%	27
2022 Q3	$1.03M	Hold	14,465	–	–	0.41%	41
2022 Q2	$1.11M	Sell	14,465 -520	-3%	-$39.6K	0.43%	42
2022 Q1	$1.09M	Hold	14,985	–	–	0.35%	47
2021 Q4	$934K	Sell	14,985 -60,287	-80%	-$3.54M	0.27%	49
2021 Q3	$4.45M	Buy	75,272 +225	+0.3%	+$14.8K	1.37%	19
2021 Q2	$5.01M	Buy	75,047 +60,160	+404%	+$3.92M	1.48%	17
2021 Q1	$940K	Buy	14,887 +110	+0.7%	+$6.84K	0.29%	49
2020 Q4	$917K	Hold	14,777	–	–	0.29%	47
2020 Q3	$891K	Hold	14,777	–	–	0.33%	46
2020 Q2	$869K	Hold	14,777	–	–	0.36%	46
2020 Q1	$824K	Sell	14,777 -4,400	-23%	-$269K	0.4%	46
2019 Q4	$1.23M	Buy	19,177 +8,837	+85%	+$506K	0.49%	43
2019 Q3	$524K	Buy	10,340 +300	+3%	+$14.1K	0.23%	50
2019 Q2	$455K	Hold	10,040	–	–	0.2%	51
2019 Q1	$479K	Hold	10,040	–	–	0.24%	50
2018 Q4	$522K	Hold	10,040	–	–	0.27%	54
2018 Q3	$623K	Hold	10,040	–	–	0.27%	57
2018 Q2	$556K	Sell	10,040 -40,955	-80%	-$2.21M	0.26%	57
2018 Q1	$3.23M	Sell	50,995 -35	-0.1%	-$2.25K	1.49%	17
2017 Q4	$3.13M	Sell	51,030 -155	-0.3%	-$9.7K	1.46%	16
2017 Q3	$3.26M	Sell	51,185 -610	-1%	-$35.6K	1.62%	12
2017 Q2	$2.89M	Buy	51,795 +25	+0%	+$1.36K	1.52%	15
2017 Q1	$2.81M	Buy	51,770 +770	+2%	+$42.2K	1.6%	17
2016 Q4	$2.98M	Sell	51,000 -8,715	-15%	-$476K	1.76%	17
2016 Q3	$3.22M	Buy	59,715 +48,675	+441%	+$3.13M	1.86%	14
2016 Q2	$812K	Hold	11,040	–	–	0.49%	45
2016 Q1	$705K	Hold	11,040	–	–	0.43%	48
2015 Q4	$759K	Hold	11,040	–	–	0.49%	47
2015 Q3	$654K	Hold	11,040	–	–	0.43%	48
2015 Q2	$735K	Buy	11,040 +220	+2%	+$14.5K	0.45%	48
2015 Q1	$698K	Buy	10,820 +220	+2%	+$13.8K	0.5%	43
2014 Q4	$626K	Hold	10,600	–	–	0.45%	45
2014 Q3	$543K	Hold	10,600	–	–	0.42%	45
2014 Q2	$514K	Hold	10,600	–	–	0.38%	47
2014 Q1	$551K	Hold	10,600	–	–	0.44%	44
2013 Q4	$563K	Hold	10,600	–	–	0.45%	45
2013 Q3	$491K	Hold	10,600	–	–	0.42%	46
2013 Q2	$458K	Buy	+10,600	New	+$460K	0.4%	46

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Meridian Management's BMY Position: Q1 2026 in Review

Meridian Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 14,037 shares worth $851K. The position accounts for 0.21% of the portfolio, ranked #56.

Meridian Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.01M in Q2 2021. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Meridian Management held 14,037 shares of Bristol-Myers Squibb worth $851K as of Q1 2026.
Meridian Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.21% of Meridian Management's portfolio in Q1 2026, its #56 holding.
Meridian Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
Meridian Management's Bristol-Myers Squibb position peaked at $5.01M in Q2 2021.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Meridian Management's 13F filing for Q1 2026, filed 5 May 2026.